Tigermed
Chris Hay has a diverse work experience in the field of clinical research and project management. Chris worked at Tigermed as an Associate Project Director from 2023 onwards. Prior to that, they worked at IQVIA from 2012 to 2023, where they held various roles including Associate Director, IQVIA Precision Enrollment Global Patient & Site Solutions, Associate Director, Oncology Project Leadership, Sr. Clinical Project Manager, Oncology, Project Leadership, and Clinical Project Manager. Chris also has experience at BC Cancer Agency as a Clinical Trials Monitor and Project Manager from 2007 to 2011, at Ozmosis Research Inc. as a Clinical Research Monitor from 2010 to 2011, and at PRA International as a Lead Clinical Data Coordinator II from 2005 to 2007.
Chris Hay attended Simon Fraser University from 2000 to 2004, where they obtained a Bachelor of Science degree in Molecular Biology and Biochemistry. Chris also completed a Bachelor's degree with honors in Molecular Biology and Biochemistry at Simon Fraser University, although the specific years of this achievement are unknown.
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.